182 related articles for article (PubMed ID: 16942611)
1. Wnt expression is not correlated with beta-catenin dysregulation in Dupuytren's Disease.
O'Gorman DB; Wu Y; Seney S; Zhu RD; Gan BS
J Negat Results Biomed; 2006 Aug; 5():13. PubMed ID: 16942611
[TBL] [Abstract][Full Text] [Related]
2. Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.
Vi L; Njarlangattil A; Wu Y; Gan BS; O'Gorman DB
BMC Musculoskelet Disord; 2009 Jun; 10():72. PubMed ID: 19545383
[TBL] [Abstract][Full Text] [Related]
3. Identification of biomarkers in Dupuytren's disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes.
Shih B; Wijeratne D; Armstrong DJ; Lindau T; Day P; Bayat A
J Hand Surg Am; 2009 Jan; 34(1):124-36. PubMed ID: 19121738
[TBL] [Abstract][Full Text] [Related]
4. Expression of a novel gene, MafB, in Dupuytren's disease.
Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
[TBL] [Abstract][Full Text] [Related]
5. Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture.
Qian A; Meals RA; Rajfer J; Gonzalez-Cadavid NF
Urology; 2004 Aug; 64(2):399-404. PubMed ID: 15302515
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren's disease cells are regulated by tension in vitro.
Howard JC; Varallo VM; Ross DC; Roth JH; Faber KJ; Alman B; Gan BS
BMC Musculoskelet Disord; 2003 Jul; 4():16. PubMed ID: 12866952
[TBL] [Abstract][Full Text] [Related]
7. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
[TBL] [Abstract][Full Text] [Related]
8. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
[TBL] [Abstract][Full Text] [Related]
9. Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome.
Rehman S; Salway F; Stanley JK; Ollier WE; Day P; Bayat A
J Hand Surg Am; 2008 Mar; 33(3):359-72. PubMed ID: 18343292
[TBL] [Abstract][Full Text] [Related]
10. Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-β inducible p38 MAPK pathway.
Ratkaj I; Bujak M; Jurišić D; Baus Lončar M; Bendelja K; Pavelić K; Kraljević Pavelić S
Cell Physiol Biochem; 2012; 30(4):927-42. PubMed ID: 22965824
[TBL] [Abstract][Full Text] [Related]
11. Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat.
Satish L; Palmer B; Liu F; Papatheodorou L; Rigatti L; Baratz ME; Kathju S
BMC Musculoskelet Disord; 2015 Jun; 16():138. PubMed ID: 26049932
[TBL] [Abstract][Full Text] [Related]
12. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
[TBL] [Abstract][Full Text] [Related]
13. MMP-14 and MMP-2 are key metalloproteases in Dupuytren's disease fibroblast-mediated contraction.
Wilkinson JM; Davidson RK; Swingler TE; Jones ER; Corps AN; Johnston P; Riley GP; Chojnowski AJ; Clark IM
Biochim Biophys Acta; 2012 Jun; 1822(6):897-905. PubMed ID: 22342364
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin expression in Dupuytren's disease: potential role for cell-matrix interactions in modulating beta-catenin levels in vivo and in vitro.
Varallo VM; Gan BS; Seney S; Ross DC; Roth JH; Richards RS; McFarlane RM; Alman B; Howard JC
Oncogene; 2003 Jun; 22(24):3680-4. PubMed ID: 12802275
[TBL] [Abstract][Full Text] [Related]
15. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.
Vi L; Feng L; Zhu RD; Wu Y; Satish L; Gan BS; O'Gorman DB
Exp Cell Res; 2009 Dec; 315(20):3574-86. PubMed ID: 19619531
[TBL] [Abstract][Full Text] [Related]
16. Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility.
Staats KA; Wu T; Gan BS; O'Gorman DB; Ophoff RA
J Dermatol Sci; 2016 Aug; 83(2):131-7. PubMed ID: 27245865
[TBL] [Abstract][Full Text] [Related]
17. Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's Contracture.
Satish L; LaFramboise WA; Johnson S; Vi L; Njarlangattil A; Raykha C; Krill-Burger JM; Gallo PH; O'Gorman DB; Gan BS; Baratz ME; Ehrlich GD; Kathju S
BMC Med Genomics; 2012 May; 5():15. PubMed ID: 22559715
[TBL] [Abstract][Full Text] [Related]
18. Unique microRNA profile in Dupuytren's contracture supports deregulation of β-catenin pathway.
Mosakhani N; Guled M; Lahti L; Borze I; Forsman M; Pääkkönen V; Ryhänen J; Knuutila S
Mod Pathol; 2010 Nov; 23(11):1544-52. PubMed ID: 20676061
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2.
Tse R; Howard J; Wu Y; Gan BS
BMC Musculoskelet Disord; 2004 Nov; 5(1):41. PubMed ID: 15541177
[TBL] [Abstract][Full Text] [Related]
20. A complete expression profile of matrix-degrading metalloproteinases in Dupuytren's disease.
Johnston P; Chojnowski AJ; Davidson RK; Riley GP; Donell ST; Clark IM
J Hand Surg Am; 2007 Mar; 32(3):343-51. PubMed ID: 17336841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
